BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29732526)

  • 1. Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression.
    de Sousa CNS; Meneses LN; Vasconcelos GS; da Silva Medeiros I; Silva MCC; Mouaffak F; Kebir O; da Silva Leite CMG; Patrocinio MCA; Macedo D; Vasconcelos SMM
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Aug; 391(8):803-817. PubMed ID: 29732526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice.
    Silva MC; de Sousa CN; Gomes PX; de Oliveira GV; Araújo FY; Ximenes NC; da Silva JC; Vasconcelos GS; Leal LK; Macêdo D; Vasconcelos SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():142-8. PubMed ID: 26265141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of corticosterone-induced BDNF alterations by the natural antioxidant alpha-lipoic acid alone and combined with desvenlafaxine: Emphasis on the neurotrophic hypothesis of depression.
    de Sousa CN; Meneses LN; Vasconcelos GS; Silva MC; da Silva JC; Macêdo D; de Lucena DF; Vasconcelos SM
    Psychiatry Res; 2015 Dec; 230(2):211-9. PubMed ID: 26350703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain antioxidant effect of mirtazapine and reversal of sedation by its combination with alpha-lipoic acid in a model of depression induced by corticosterone.
    Oliveira TQ; de Sousa CNS; Vasconcelos GS; de Sousa LC; de Oliveira AA; Patrocínio CFV; Medeiros IDS; Honório Júnior JER; Maes M; Macedo D; Vasconcelos SMM
    J Affect Disord; 2017 Sep; 219():49-57. PubMed ID: 28521187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression?
    Silva MC; de Sousa CN; Sampaio LR; Ximenes NC; Araújo PV; da Silva JC; de Oliveira SL; Sousa FC; Macêdo DS; Vasconcelos SM
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):685-95. PubMed ID: 23584634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoic acid prevents mirtazapine-induced weight gain in mice without impairs its antidepressant-like action in a neuroendocrine model of depression.
    Oliveira TQ; Chaves Filho AJM; Jucá PM; Soares MVR; Cunha NL; Vieira CFX; Gadelha Filho CVJ; Viana GA; De Oliveira GMF; Macedo DS; Vasconcelos SMM
    Behav Brain Res; 2022 Feb; 419():113667. PubMed ID: 34798169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single administration of ascorbic acid rapidly reverses depressive-like behavior and hippocampal synaptic dysfunction induced by corticosterone in mice.
    Fraga DB; Camargo A; Olescowicz G; Azevedo Padilha D; Mina F; Budni J; Brocardo PS; Rodrigues ALS
    Chem Biol Interact; 2021 Jun; 342():109476. PubMed ID: 33872575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice.
    Ali SH; Madhana RM; K V A; Kasala ER; Bodduluru LN; Pitta S; Mahareddy JR; Lahkar M
    Steroids; 2015 Sep; 101():37-42. PubMed ID: 26048446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferulic acid reverses depression-like behavior and oxidative stress induced by chronic corticosterone treatment in mice.
    Zeni ALB; Camargo A; Dalmagro AP
    Steroids; 2017 Sep; 125():131-136. PubMed ID: 28733038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of oxidative pathways and BDNF in the antidepressant effect of carvedilol in a depression model induced by chronic unpredictable stress.
    de Sousa CNS; Medeiros IDS; Vasconcelos GS; de Aquino GA; Cysne Filho FMS; de Almeida Cysne JC; Macêdo DS; Vasconcelos SMM
    Psychopharmacology (Berl); 2022 Jan; 239(1):297-311. PubMed ID: 35022822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered acoustic startle, prepulse facilitation, and object recognition memory produced by corticosterone withdrawal in male rats.
    Brymer KJ; Kulhaway EY; Howland JG; Caruncho HJ; Kalynchuk LE
    Behav Brain Res; 2021 Jun; 408():113291. PubMed ID: 33836169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine.
    Macêdo DS; Medeiros CD; Cordeiro RC; Sousa FC; Santos JV; Morais TA; Hyphantis TN; McIntyre RS; Quevedo J; Carvalho AF
    Bipolar Disord; 2012 Nov; 14(7):707-18. PubMed ID: 22897629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of alpha-lipoic acid effect on memory impairment considering strain-dependent differences in mice.
    Ghafour-Boroujerdi E; Rahmani S; Sanadgol N; Baeeri M; Hassani S
    Life Sci; 2021 Sep; 281():119766. PubMed ID: 34186041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive-like behavior and cognitive impairment induced by acute administration of dexamethasone: Pharmacological effects of 2-phenyl-3-(phenylselanyl)benzofuran in female Swiss mice.
    Strelow DN; Magalhães LS; Paim MP; Krüger LD; Neto JSS; Brüning CA; Bortolatto CF
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jul; 125():110772. PubMed ID: 37075882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-lipoic acid-mediated activation of muscarinic receptors improves hippocampus- and amygdala-dependent memory.
    Mahboob A; Farhat SM; Iqbal G; Babar MM; Zaidi NU; Nabavi SM; Ahmed T
    Brain Res Bull; 2016 Apr; 122():19-28. PubMed ID: 26912408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice.
    Machado DG; Cunha MP; Neis VB; Balen GO; Colla AR; Grando J; Brocardo PS; Bettio LE; Dalmarco JB; Rial D; Prediger RD; Pizzolatti MG; Rodrigues AL
    J Ethnopharmacol; 2012 Aug; 143(1):158-69. PubMed ID: 22721880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice.
    Gupta D; Radhakrishnan M; Kurhe Y
    Steroids; 2015 Apr; 96():95-102. PubMed ID: 25668613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-environment interaction of reelin and stress in cognitive behaviours in mice: Implications for schizophrenia.
    Schroeder A; Buret L; Hill RA; van den Buuse M
    Behav Brain Res; 2015; 287():304-14. PubMed ID: 25845740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined corticosterone treatment and chronic restraint stress lead to depression associated with early cognitive deficits in mice.
    Ngoupaye GT; Yassi FB; Bahane DAN; Bum EN
    Metab Brain Dis; 2018 Apr; 33(2):421-431. PubMed ID: 29199383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.